Cite
ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma.
MLA
Li, Juan, et al. “ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma.” BioMed Research International, July 2022, pp. 1–15. EBSCOhost, https://doi.org/10.1155/2022/5328192.
APA
Li, J., Yang, D., Zhang, C., Wei, S., Zhao, R., Dai, S., & Shan, B. (2022). ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma. BioMed Research International, 1–15. https://doi.org/10.1155/2022/5328192
Chicago
Li, Juan, Dong Yang, Cong Zhang, Sisi Wei, Ruinian Zhao, Suli Dai, and Baoen Shan. 2022. “ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma.” BioMed Research International, July, 1–15. doi:10.1155/2022/5328192.